Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
- PMID: 1652368
- DOI: 10.1016/0092-8674(91)90112-c
Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML
Abstract
A unique mRNA produced in leukemic cells from a t(15;17) acute promyelocytic leukemia (APL) patient encodes a fusion protein between the retinoic acid receptor alpha (RAR alpha) and a myeloid gene product called PML. PML contains a cysteine-rich region present in a new family of apparent DNA-binding proteins that includes a regulator of the interleukin-2 receptor gene (Rpt-1) and the recombination-activating gene product (RAG-1). Accordingly, PML may represent a novel transcription factor or recombinase. The aberrant PML-RAR fusion product, while typically retinoic acid responsive, displays both cell type- and promoter-specific differences from the wild-type RAR alpha. Because patients with APL can be induced into remission with high dose RA therapy, we propose that the nonliganded PML-RAR protein is a new class of dominant negative oncogene product. Treatment with RA would not only relieve this inhibition, but the activated PML-RAR protein may actually promote myelocyte differentiation.
Similar articles
-
The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR.Cell. 1991 Aug 23;66(4):675-84. doi: 10.1016/0092-8674(91)90113-d. Cell. 1991. PMID: 1652369
-
Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.Oncogene. 1995 Jun 15;10(12):2307-14. Oncogene. 1995. PMID: 7784078
-
Acute promyelocytic leukemia: from clinic to molecular biology.Stem Cells. 1995 Jan;13(1):22-31. doi: 10.1002/stem.5530130104. Stem Cells. 1995. PMID: 7719245 Review.
-
The molecular genetics of acute promyelocytic leukemia.Blood Rev. 1993 Jun;7(2):87-93. doi: 10.1016/s0268-960x(05)80018-9. Blood Rev. 1993. PMID: 8396481 Review.
-
The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.Oncogene. 1994 Feb;9(2):545-51. Oncogene. 1994. PMID: 8290265
Cited by
-
Does the pursuit of scientific excellence serve or hamper translational medical research: an historical perspective from hematological malignancies.Blood Cancer J. 2022 Oct 7;12(10):142. doi: 10.1038/s41408-022-00738-x. Blood Cancer J. 2022. PMID: 36202796 Free PMC article. Review.
-
Cancer stem cells and tumor transdifferentiation: implications for novel therapeutic strategies.Am J Stem Cells. 2013 Mar 8;2(1):52-61. Print 2013. Am J Stem Cells. 2013. PMID: 23671816 Free PMC article.
-
Cancer Stem Cells: Formidable Allies of Cancer.Indian J Surg Oncol. 2015 Dec;6(4):400-14. doi: 10.1007/s13193-015-0451-7. Epub 2015 Aug 19. Indian J Surg Oncol. 2015. PMID: 27081258 Free PMC article.
-
The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA.Mol Cell Biol. 1992 Apr;12(4):1687-97. doi: 10.1128/mcb.12.4.1687-1697.1992. Mol Cell Biol. 1992. PMID: 1549122 Free PMC article.
-
Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.Mol Cell Biol. 2008 Feb;28(3):997-1006. doi: 10.1128/MCB.01848-07. Epub 2007 Nov 26. Mol Cell Biol. 2008. PMID: 18039859 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases